Diabetes research improves treatment

Researchers from the University of Dundee have made an important discovery about the world’s most commonly prescribed diabetes medicine, which also protects against cancer and cardiovascular disease, opening up the possibility of developing more effective treatments.

The Dundee team, led by Dr Graham Rena of the Department of Cardiovascular and Diabetes Medicine, has furthered under-standing of how the type 2 diabetes drug metformin works. They believe this may allow scientists to develop more effective ‘second-generation’ medicines. The research, funded by Tenovus Scotland, appears in a paper in the current edition of the journal Diabetes.